Relatedly, the importance of MEK targeting observed in this study is particularly timely with the recent identification of single agent MEK inhibition being the most active therapy for plexiform neurofibromas, precursor lesions for MPNST [52]. Here, MAP2K7 is linked to plexiform neurofibroma.